Interacting Drugs |
Daclizumab vs BCG |
Security Level |
|
Mechanism |
BCG: Immunosuppressants may diminish the therapeutic effect of BCG. |
Management |
Avoid combination |
Daclizumab vs BCG
Post Review about Daclizumab vs BCG Click here to cancel reply.
Other Interactions of Daclizumab
Other Interactions of BCG
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.